Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans

Br J Dermatol. 2004 Jul;151(1):235-7. doi: 10.1111/j.1365-2133.2004.06024.x.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Dermatofibrosarcoma / diagnosis
  • Dermatofibrosarcoma / drug therapy*
  • Humans
  • Imatinib Mesylate
  • Lumbosacral Region
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Tomography, Emission-Computed
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate